Vikram Bhise

425 total citations
19 papers, 273 citations indexed

About

Vikram Bhise is a scholar working on Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Vikram Bhise has authored 19 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Vikram Bhise's work include Multiple Sclerosis Research Studies (7 papers), Genomics and Rare Diseases (2 papers) and Brain Metastases and Treatment (2 papers). Vikram Bhise is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Genomics and Rare Diseases (2 papers) and Brain Metastases and Treatment (2 papers). Vikram Bhise collaborates with scholars based in United States, Netherlands and Sweden. Vikram Bhise's co-authors include David E. Mandelbaum, Gail Burack, Lauren Krupp, Suhayl Dhib‐Jalbut, Yashma Patel, Daniel Greenblatt, Mirjana Maletić‐Savatić, Dana Serafin, Mark E. Wagshul and Christopher Christodoulou and has published in prestigious journals such as NeuroImage, Neurology and Developmental Medicine & Child Neurology.

In The Last Decade

Vikram Bhise

17 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikram Bhise United States 8 124 94 63 57 42 19 273
Francesco Manfredonia United Kingdom 9 130 1.0× 73 0.8× 31 0.5× 64 1.1× 10 0.2× 15 296
J. Tamraz France 10 32 0.3× 38 0.4× 60 1.0× 63 1.1× 36 0.9× 37 316
Marcelo Budke Spain 9 38 0.3× 74 0.8× 67 1.1× 15 0.3× 16 0.4× 23 219
Laia Grau‐López Spain 14 211 1.7× 116 1.2× 50 0.8× 11 0.2× 30 0.7× 40 690
Annacarmen Nilo Italy 11 36 0.3× 131 1.4× 81 1.3× 14 0.2× 15 0.4× 39 301
Seung‐Hyun Kim South Korea 13 356 2.9× 27 0.3× 32 0.5× 102 1.8× 18 0.4× 78 548
Arif O. Khan Saudi Arabia 15 150 1.2× 49 0.5× 20 0.3× 300 5.3× 69 1.6× 61 756
Ahmad Rithauddin Mohamed Malaysia 6 45 0.4× 83 0.9× 85 1.3× 74 1.3× 36 0.9× 21 358
Seher Naz Yenı Türkiye 10 25 0.2× 275 2.9× 153 2.4× 42 0.7× 20 0.5× 39 364
R. Lévy France 11 38 0.3× 15 0.2× 49 0.8× 56 1.0× 22 0.5× 34 279

Countries citing papers authored by Vikram Bhise

Since Specialization
Citations

This map shows the geographic impact of Vikram Bhise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Bhise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Bhise more than expected).

Fields of papers citing papers by Vikram Bhise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Bhise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Bhise. The network helps show where Vikram Bhise may publish in the future.

Co-authorship network of co-authors of Vikram Bhise

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Bhise. A scholar is included among the top collaborators of Vikram Bhise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Bhise. Vikram Bhise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hundal, Jasdeep, et al.. (2025). Coffin-Lowry Syndrome: A Case of Clinical Convergence for Psychology, Neuropsychology, Psychiatry, Genetics, and Neurology. Journal of Child Neurology. 40(5). 374–378. 1 indexed citations
2.
Quinn, Carson, Prashanth Rajarajan, Alexander J. Gill, et al.. (2024). Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. Neurology. 103(11). e210003–e210003. 5 indexed citations
3.
Quinn, Carson, Prashanth Rajarajan, Andrew B. Wolf, et al.. (2024). Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications (PL4.004). Neurology. 102(7_supplement_1). 2 indexed citations
4.
Jiménez, Manuel, et al.. (2024). No one really plans to have multiple sclerosis: Transition readiness and quality of life in paediatric multiple sclerosis. Child Care Health and Development. 50(4). e13304–e13304. 1 indexed citations
5.
Quinn, Carson, Prashanth Rajarajan, Andrew B. Wolf, et al.. (2024). Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors. Neurology. 103(7_Supplement_1).
6.
Hamed, Ahlam A., Mahmoud Koko, Liena E. O. Elsayed, et al.. (2024). A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes. Neurogenetics. 25(4). 425–433.
8.
Greenberg, Patricia, et al.. (2024). Seroprevalence of Lyme Disease in Children With Facial Nerve Palsy. Journal of Child Neurology. 39(9-10). 310–316. 1 indexed citations
9.
Horton, Daniel B., et al.. (2023). Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020. JAMA Neurology. 80(8). 860–860. 15 indexed citations
10.
Bhise, Vikram & Suhayl Dhib‐Jalbut. (2021). Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives. Neurotherapeutics. 18(1). 244–251. 16 indexed citations
11.
Roychowdhury, Sudipta, et al.. (2020). Tentorium and Straight Sinus Hypoplasia in a Child: a Case Report. SN Comprehensive Clinical Medicine. 2(7). 974–977. 1 indexed citations
12.
Bhise, Vikram, et al.. (2019). Case 1: Sudden Bilateral Lower Extremity Weakness and Urinary Incontinence in a 13-year-old Girl. Pediatrics in Review. 40(10). 528–531. 1 indexed citations
13.
Brooks, Susan Sklower, et al.. (2018). Further Delineation of Ribose-5-phosphate Isomerase Deficiency: Report of a Third Case. Journal of Child Neurology. 33(12). 784–787. 6 indexed citations
14.
Bhise, Vikram & Suhayl Dhib‐Jalbut. (2016). Further understanding of the immunopathology of multiple sclerosis: impact on future treatments. Expert Review of Clinical Immunology. 12(10). 1069–1089. 18 indexed citations
15.
Bhise, Vikram, Leigh Charvet, & Lauren Krupp. (2016). Fatigue in Multiple Sclerosis. Oxford University Press eBooks. 12 indexed citations
16.
Yu, Hui Jing, Christopher Christodoulou, Vikram Bhise, et al.. (2011). Multiple white matter tract abnormalities underlie cognitive impairment in RRMS. NeuroImage. 59(4). 3713–3722. 88 indexed citations
17.
Bhise, Vikram, Gail Burack, & David E. Mandelbaum. (2009). Baseline cognition, behavior, and motor skills in children with new‐onset, idiopathic epilepsy. Developmental Medicine & Child Neurology. 52(1). 22–26. 59 indexed citations
18.
Krupp, Lauren, Yashma Patel, & Vikram Bhise. (2009). Pediatric multiple sclerosis. Annals of Indian Academy of Neurology. 12(4). 238–238. 18 indexed citations
19.
Mandelbaum, David E., Gail Burack, & Vikram Bhise. (2009). Impact of antiepileptic drugs on cognition, behavior, and motor skills in children with new-onset, idiopathic epilepsy. Epilepsy & Behavior. 16(2). 341–344. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026